Septerna, Inc.

SEPN Nasdaq SEC CIK 1984086
Follow Septerna Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $18.9M −12.2% vs same quarter last year
Net income −$26.6M −425.3% vs same quarter last year
EPS, diluted −$0.57 −416.7% vs same quarter last year
Operating cash flow −$13.8M −108.2% vs same quarter last year
Revenue by quarter
$212K
$219K
$119K
$21.5M
$24.1M
$26.5M
$26.7M
$18.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50MFY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$46M−$48.9M
FY24$1.1M−$71.8M
FY23$151K$4.2M
FY22--
MarginsShare of revenue
  • Operating margin
  • Net margin
−10000%−5000%0%5000%FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−148.6%−106.4%
FY24−7518.4%−6678.9%
FY231374.2%2768.2%
FY22--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50M$100M$150MFY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$109.7M
FY24−$69.6M
FY23−$41.6M
FY22-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Septerna
  • Healthcare median
−7500%−5000%−2500%0%2500%5000%FY22FY23FY24FY25
Show the numbers
YearSepternaHealthcare median
FY25−106.4%−30.6%
FY24−6678.9%−47%
FY232768.2%−58%
FY22-−80.4%